Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases for which there is currently no effective vaccine or where existing treatments are poorly effective. Bionor Immuno AS aims to develop its therapeutic products through phase II clinical trials. Phase III clinical trials, manufacturing and marketing of finished products will be done in co-operation with a licensing partner

Contact Details: P.O. Box 1823 Skien 3703 Norway Tel: 47 35 50 57 50 Fax: 47 35 50 57 01 Email: info@bionorimmuno.com WWW: www.bionorimmuno.com/

Recent Publications by Bionor Immuno AS:
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x). Delayed-type hypersensitivity (DTH) testing represents a simple in vivo...	13th May, 2006	Bionor Immuno AS, P.O. Box. 1823, NO-3703 Skien, Norway.	Vaccine. 2006 Mar 6;24(10):1543-50. Epub 2005 Nov 2. DOI Direct Link
Novel peptide-based HIV-1 immunotherapy. Therapeutic immunisation of human immunodeficiency virus type 1-infected...	14th July, 2004	Bionor Immuno AS, Stromdaljordet 4, PO Box 1823 Gulset, NO-3703 Skien,	Expert Opin Biol Ther. 2004 Mar;4(3):349-61. DOI Direct Link

BioNews Results for Bionor Immuno AS:
Saskatchewan marks first swine flu-related death as numbers also rise in Quebec	Oldies 1310:  Jun 29 2009 1:30AM Matching: immuno
Saskatchewan marks first swine flu-related death as numbers also rise in Quebec	Yahoo! Canada:  Jun 29 2009 12:47AM Matching: immuno
Saskatchewan marks first swine flu-related death as numbers also rise in Quebec	660 News:  Jun 29 2009 12:23AM Matching: immuno
Saskatchewan marks first swine flu-related death as numbers also rise in Quebec	Newstalk 1290 CJBK:  Jun 28 2009 11:56PM Matching: immuno
Saskatchewan marks first swine flu-related death as numbers also rise in Quebec	CJAD 800:  Jun 28 2009 11:27PM Matching: immuno
Promote your company here: BioNewsCast - Press Release Distribution	→View more Bionor Immuno AS news.

Bionor Immuno AS Patents:
US Patent No.	Title
7097971	HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit
7009037	Modified HIV-1gag p17 peptide and immunogenic composition
6706859	HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 577 times since April 2007, the link to the organisation's website has been followed 114 times

Recent Search Terms used to find this page: bionor immuno hiv | Vacc-4x patent | bionor immuno patent | Bionor Immuno AS | Bionor Immuno AS | DTH with Bionor HIV vaccine | bionor immuno | t | t | bionor immuno as | .

Search for more companies in Skien

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Bionor Immuno AS